Total net revenue of $15.2 million Adjusted EBITDA1 of $ (0.8) million, which includes EXXUA launch investments $30.0 million cash balance at December 31, 2025 Company launched EXXUA™ (gepirone) ...
Q3 2026 Earnings Call February 3, 2026 4:30 PM ESTCompany ParticipantsJohn HoweLee Rudow - President, CEO & DirectorThomas ...
AIM ImmunoTech Inc. (NYSE American: AIM) - AIM ImmunoTech Inc. ("AIM" or the "Company"), an immuno-pharma company focused on the research and development ...
As informational search declines, digital PR is driving authority, relevance, and high-intent results in SEO. Here’s how it works.
For a limited time, customers can enjoy up to 7 months’ premium refund[2] upon successful application with tax deduction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results